News AZ to file COPD combo in China and Japan AstraZeneca is planning filings of its chronic obstructive pulmonary disease drug Bevespi Aerosphere in China and Japan, based on a new set of positive phase 3 trial results.
News GSK and Propeller prepare to launch digital inhaler Deal expands to a commercialisation partnership to prepare for US and Europe marketing.
News Verona pushes on with COPD drug after £70m fundraiser UK biotech hopes RPL554 could be a disease modifying drug.
News After Hikma and Mylan fail, Sandoz files Advair generic in U... FDA accepts Sandoz filing for Advair Diskus generic.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
